Recombinant HBHA Boosting Effect on BCG-Induced Immunity againstMycobacterium tuberculosisInfection
Open Access
- 1 January 2011
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2011, 1-8
Abstract
Heterologous prime-boost regimens are effective strategies to promote long-term memory and strong cellular Th1 responses toMycobacterium tuberculosis, when BCG is used in the priming step. Subcutaneous or intranasal boosting of BCG-vaccinated newborn mice with native heparin-binding haemagglutinin (nHBHA) significantly enhances protection againstM. tuberculosis.However, nHBHA is characterized by a complex methylation pattern in its C-terminal domain, which is important for protective immunogenicity in primary vaccination. In this study we addressed the question whether boosting with recombinant, non-methylated HBHA (rHBHA) produced inEscherichia colimay enhance protection of BCG-primed newborn mice. We found that while subcutaneous rHBHA boosting enhanced protection of BCG-primed mice against intranasalM. tuberculosisinfection both in spleen and lungs, enhanced protection against aerosol infection was only seen in the spleen (0.72 logs;) but not in the lungs. Thus, in BCG-primed mice the methylation of the C-terminal domain of HBHA is dispensable for the induction of enhanced protection in the lungs against intranasal but not aerosol infection, whereas it enhances protection in the spleen in both challenge models. This report thus provides evidence that rHBHA may be considered as a booster vaccine against disseminated tuberculosis.
Keywords
Funding Information
- European Commission (LSHP-CT-2005-018736)
This publication has 36 references indexed in Scilit:
- Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosisJournal of Experimental Medicine, 2010
- IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platformJournal of Experimental Medicine, 2010
- Cell-Mediated Immune Responses in TuberculosisAnnual Review of Immunology, 2009
- The coiled-coil N-terminal domain of the heparin-binding haemagglutinin is required for the humoral and cellular immune responses in miceMolecular Immunology, 2008
- Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy TrialsPLOS ONE, 2007
- Tuberculosis subunit vaccines: from basic science to clinical testingExpert Opinion on Biological Therapy, 2007
- Interleukin-12 and tuberculosis: an old story revisitedCurrent Opinion in Immunology, 2007
- IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challengeNature Immunology, 2007
- An Increase in Antimycobacterial Th1-Cell Responses by Prime-Boost Protocols of Immunization Does Not Enhance Protection against TuberculosisInfection and Immunity, 2006
- Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivoNature Immunology, 2002